Efficacy and safety of high infusion rate IVIG in CIDP.

Yue JiangMeg MendozaEvelyn SarpongShabber MannanEduardo NgHans KatzbergVera BrilCarolina Barnett-Tapia

Published in: Muscle & nerve (2020)

We found that 10% IVIG can be safely administered at a high infusion rate (0.14 ml/kg/min) in most CIDP patients, reducing the treatment time and burden on healthcare resources.

Keyphrases

healthcare
end stage renal disease
low dose
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
smoking cessation
health insurance